226 related articles for article (PubMed ID: 26683094)
41. Cancer Subtype Discovery Based on Integrative Model of Multigenomic Data.
Ge SG; Xia J; Sha W; Zheng CH
IEEE/ACM Trans Comput Biol Bioinform; 2017; 14(5):1115-1121. PubMed ID: 28113782
[TBL] [Abstract][Full Text] [Related]
42. The Discovery of Mutated Driver Pathways in Cancer: Models and Algorithms.
Zhang J; Zhang S
IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(3):988-998. PubMed ID: 28113329
[TBL] [Abstract][Full Text] [Related]
43. Local network component analysis for quantifying transcription factor activities.
Shi Q; Zhang C; Guo W; Zeng T; Lu L; Jiang Z; Wang Z; Liu J; Chen L
Methods; 2017 Jul; 124():25-35. PubMed ID: 28710010
[TBL] [Abstract][Full Text] [Related]
44. Identification of ovarian cancer associated genes using an integrated approach in a Boolean framework.
Kumar G; Breen EJ; Ranganathan S
BMC Syst Biol; 2013 Feb; 7():12. PubMed ID: 23383610
[TBL] [Abstract][Full Text] [Related]
45. Detection of Combinatorial Mutational Patterns in Human Cancer Genomes by Exclusivity Analysis.
Tan H; Zhou X
Methods Mol Biol; 2018; 1711():3-11. PubMed ID: 29344882
[TBL] [Abstract][Full Text] [Related]
46. Identifying mutated driver pathways in cancer by integrating multi-omics data.
Wu J; Cai Q; Wang J; Liao Y
Comput Biol Chem; 2019 Jun; 80():159-167. PubMed ID: 30959272
[TBL] [Abstract][Full Text] [Related]
47. CM-viewer: Visualizing interaction network of co-mutated and mutually exclusively mutated cancer genes.
Zhou N; Hu Z; Wu C; Bao J
Biosystems; 2018 Apr; 166():37-42. PubMed ID: 29278730
[TBL] [Abstract][Full Text] [Related]
48. Identification of supervised and sparse functional genomic pathways.
Zhang F; Miecznikowski JC; Tritchler DL
Stat Appl Genet Mol Biol; 2020 Feb; 19(1):. PubMed ID: 32109224
[TBL] [Abstract][Full Text] [Related]
49. Our changing view of the genomic landscape of cancer.
Bell DW
J Pathol; 2010 Jan; 220(2):231-43. PubMed ID: 19918804
[TBL] [Abstract][Full Text] [Related]
50. TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data.
Colaprico A; Silva TC; Olsen C; Garofano L; Cava C; Garolini D; Sabedot TS; Malta TM; Pagnotta SM; Castiglioni I; Ceccarelli M; Bontempi G; Noushmehr H
Nucleic Acids Res; 2016 May; 44(8):e71. PubMed ID: 26704973
[TBL] [Abstract][Full Text] [Related]
51. Derivation of a fifteen gene prognostic panel for six cancers.
Khirade MF; Lal G; Bapat SA
Sci Rep; 2015 Aug; 5():13248. PubMed ID: 26272668
[TBL] [Abstract][Full Text] [Related]
52. High-Throughput Genomic Profiling of Adult Solid Tumors Reveals Novel Insights into Cancer Pathogenesis.
Hartmaier RJ; Albacker LA; Chmielecki J; Bailey M; He J; Goldberg ME; Ramkissoon S; Suh J; Elvin JA; Chiacchia S; Frampton GM; Ross JS; Miller V; Stephens PJ; Lipson D
Cancer Res; 2017 May; 77(9):2464-2475. PubMed ID: 28235761
[TBL] [Abstract][Full Text] [Related]
53. Exome sequencing takes centre stage in cancer profiling.
Maher B
Nature; 2009 May; 459(7244):146-7. PubMed ID: 19444175
[No Abstract] [Full Text] [Related]
54. Probabilistic model of the human protein-protein interaction network.
Rhodes DR; Tomlins SA; Varambally S; Mahavisno V; Barrette T; Kalyana-Sundaram S; Ghosh D; Pandey A; Chinnaiyan AM
Nat Biotechnol; 2005 Aug; 23(8):951-9. PubMed ID: 16082366
[TBL] [Abstract][Full Text] [Related]
55. Modeling gene-wise dependencies improves the identification of drug response biomarkers in cancer studies.
Nikolova O; Moser R; Kemp C; Gönen M; Margolin AA
Bioinformatics; 2017 May; 33(9):1362-1369. PubMed ID: 28082455
[TBL] [Abstract][Full Text] [Related]
56. Jointly analyzing gene expression and copy number data in breast cancer using data reduction models.
Berger JA; Hautaniemi S; Mitra SK; Astola J
IEEE/ACM Trans Comput Biol Bioinform; 2006; 3(1):2-16. PubMed ID: 17048389
[TBL] [Abstract][Full Text] [Related]
57. Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types.
Peng L; Bian XW; Li DK; Xu C; Wang GM; Xia QY; Xiong Q
Sci Rep; 2015 Aug; 5():13413. PubMed ID: 26292924
[TBL] [Abstract][Full Text] [Related]
58. Identify condition-specific gene co-expression networks.
Kalluru V; Machiraju R; Huang K
Int J Comput Biol Drug Des; 2013; 6(1-2):50-9. PubMed ID: 23428473
[TBL] [Abstract][Full Text] [Related]
59. Transcriptional Profiles from Paired Normal Samples Offer Complementary Information on Cancer Patient Survival--Evidence from TCGA Pan-Cancer Data.
Huang X; Stern DF; Zhao H
Sci Rep; 2016 Feb; 6():20567. PubMed ID: 26837275
[TBL] [Abstract][Full Text] [Related]
60. Cancer driver gene discovery through an integrative genomics approach in a non-parametric Bayesian framework.
Yang H; Wei Q; Zhong X; Yang H; Li B
Bioinformatics; 2017 Feb; 33(4):483-490. PubMed ID: 27797769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
